Veterinary Medicines

Atussin szirup

Authorised
  • Dextromethorphan hydrobromide
  • Chlorphenamine maleate
  • Ephedrine hydrochloride
  • Guaifenesin
Download as PDF

Product identification

Medicine name:
Atussin szirup
Active substance:
  • Dextromethorphan hydrobromide
  • Chlorphenamine maleate
  • Ephedrine hydrochloride
  • Guaifenesin
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Dextromethorphan hydrobromide
    500.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Chlorphenamine maleate
    71.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Ephedrine hydrochloride
    500.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Guaifenesin
    900.00
    milligram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Syrup
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR05FA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol Biowet Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol Biowet Sp. z o.o.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."